홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

3-methoxy-4-(4-methyl-1H-imidazol-1-yl)aniline → (R)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-6-methyl-8-phenyl-5,6,7,8-tetrahydropyrimido[5,4-f][1,4]oxazepin-2-amine

HRID 273
인쇄

반응식

HRID 273 반응식
CN1Cc2cnc(Cl)nc2O[C@H](c2ccccc2)C1.COc1cc(N)ccc1-n1cnc(C)c1>CC(=O)O.CC(=O)O.COCCOC.O=C([O-])[O-].[Cs+].[Cs+].[Pd].c1ccc(-c2ccccc2P(C2CCCCC2)C2CCCCC2)cc1>COc1cc(Nc2ncc3c(n2)O[C@H](c2ccccc2)CN(C)C3)ccc1-n1cnc(C)c1
참가 물질반응 조건실험 절차출처 및 근거반응 노트

참가 물질

7

반응물 2

HCID 454801813-methoxy-4-(4-methyl-1H-imidazol-1-yl)anilineHCID 59577867(R)-2-chloro-6-methyl-8-phenyl-5,6,7,8-tetrahydropyrimido[5,4-f][1,4]oxazepine

생성물 1

HCID 49820859(R)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-6-methyl-8-phenyl-5,6,7,8-tetrahydropyrimido[5,4-f][1,4]oxazepin-2-amine수율 6.84%

시약·촉매·용매 4

HCID 10796Cesium carbonate시약
HCID 2734216
2-(Dicyclohexylphosphino)biphenyl
촉매
HCID 4144353Palladium (II) acetate촉매
HCID 80711,2-Dimethoxyethane용매

반응 조건

온도
100 °C

실험 절차

Palladium(II) acetate (6.68 mg, 0.03 mmol), 2-(Dicyclohexylphosphino)biphenyl (10.42 mg, 0.03 mmol) and Cesium carbonate (0.388 g, 1.19 mmol) were put in a 5 mL microwave vial and sealed. The vial was flushed with argon. (R)-2-chloro-6-methyl-8-phenyl-5,6,7,8-tetrahydropyrimido[5,4-f][1,4]oxazepine (0.082 g, 0.30 mmol) in DME (5 mL) was added to the vial. The reaction mixture was run in the microwave at 100°C for 60 minutes. Forgot the aniline! Added 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)aniline (0.086 g, 0.36 mmol) and a small spatula of Palladium(II) acetate and 2-(Dicyclohexylphosphino)biphenyl and the reaction mixture was run in the microwave for 60 minutes for 100°C. The reaction mixture was filtrated through celite, concentrated and purified first by preparative chromatography. The productcontaining fractions were pooled, concentrated and partitioned between sat. NaHCO3 (aq) and dichloromethane. The organic layer was washed with sat. NaHCO3 (aq), dried (Na2SO4) and concentrated giving (R)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-6-methyl-8-phenyl-5,6,7,8-tetrahydropyrimido[5,4-f][1,4]oxazepin-2-amine (9.00 mg, 6.84 %).

출처 및 근거

ORD 기록
ord-5df7b290b65549a1949a950ac953d2d5
출처 데이터셋
750 AstraZeneca ELN dataset
원본 링크
출처 보기

반응 노트

이 페이지에서참가 물질반응 조건실험 절차출처 및 근거반응 노트